GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) » Definitions » Asset Turnover

Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Asset Turnover : 0.00 (As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is Pharbaco Central Pharmaceutical JSC No 1 Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Pharbaco Central Pharmaceutical JSC No 1's Revenue for the six months ended in . 20 was ₫ Mil. Pharbaco Central Pharmaceutical JSC No 1's Total Assets for the quarter that ended in . 20 was ₫ Mil. Therefore, Pharbaco Central Pharmaceutical JSC No 1's Asset Turnover for the quarter that ended in . 20 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Pharbaco Central Pharmaceutical JSC No 1's annualized ROE % for the quarter that ended in . 20 was %. It is also linked to ROA % through Du Pont Formula. Pharbaco Central Pharmaceutical JSC No 1's annualized ROA % for the quarter that ended in . 20 was %.


Pharbaco Central Pharmaceutical JSC No 1 Asset Turnover Historical Data

The historical data trend for Pharbaco Central Pharmaceutical JSC No 1's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharbaco Central Pharmaceutical JSC No 1 Asset Turnover Chart

Pharbaco Central Pharmaceutical JSC No 1 Annual Data
Trend
Asset Turnover

Pharbaco Central Pharmaceutical JSC No 1 Semi-Annual Data
Asset Turnover

Competitive Comparison of Pharbaco Central Pharmaceutical JSC No 1's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Pharbaco Central Pharmaceutical JSC No 1's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharbaco Central Pharmaceutical JSC No 1's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharbaco Central Pharmaceutical JSC No 1's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Pharbaco Central Pharmaceutical JSC No 1's Asset Turnover falls into.



Pharbaco Central Pharmaceutical JSC No 1 Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Pharbaco Central Pharmaceutical JSC No 1's Asset Turnover for the fiscal year that ended in . 20 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
=

Pharbaco Central Pharmaceutical JSC No 1's Asset Turnover for the quarter that ended in . 20 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Pharbaco Central Pharmaceutical JSC No 1  (HSTC:PBC) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Pharbaco Central Pharmaceutical JSC No 1's annulized ROE % for the quarter that ended in . 20 is

ROE %**(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=( / )*( / )*(/ )
=Net Margin %*Asset Turnover*Equity Multiplier
= %**
=ROA %*Equity Multiplier
= %*
= %

Note: The Net Income data used here is two times the semi-annual (. 20) net income data. The Revenue data used here is two times the semi-annual (. 20) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Pharbaco Central Pharmaceutical JSC No 1's annulized ROA % for the quarter that ended in . 20 is

Note: The Net Income data used here is two times the semi-annual (. 20) net income data. The Revenue data used here is two times the semi-annual (. 20) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Pharbaco Central Pharmaceutical JSC No 1 Asset Turnover Related Terms

Thank you for viewing the detailed overview of Pharbaco Central Pharmaceutical JSC No 1's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
160 Ton Duc Thang, Hang Bot ward, Dong Da District, Hanoi, VNM
Pharbaco Central Pharmaceutical JSC No 1 is a pharmaceutical company. Some of its products include Cefadroxil 250mg, Elnizol infusion drug, and Fabafixim 50.

Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Headlines

No Headlines